Geographic and gender variability in the prevalence of bronchial responsiveness in Canada

Chest

Volumn 125, Issue 5, 2004, Pages 1657-1664

  Manfreda, Jure ^a   Sears, Malcolm R ^b   Becklake, Margaret R ^c   Chan Yeung, Moira ^d   Dimich Ward, Helen ^d   Siersted, Hans C ^b   Ernst, Pierre ^c   Sweet, Lamont ^e   Van Til, Linda ^e   Bowie, Dennis M ^f   Anthonisen, Nicholas R ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e Dept of Health and Social Services ^*  (Canada)

^f DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Bronchial responsiveness; Gender; Geography; Prevalence; Variability

Indexed keywords

ALLERGEN; METHACHOLINE; SODIUM CHLORIDE;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; BRONCHUS REACTIVITY; CANADA; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PROTOCOL; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; FEMALE; FORCED EXPIRATORY VOLUME; GENDER; GEOGRAPHY; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; LABORATORY; LUNG FUNCTION TEST; MALE; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; PROVOCATION TEST; QUESTIONNAIRE; SAMPLING; SEX DIFFERENCE; SKIN MANIFESTATION; SKIN TEST; SMOKING; STANDARDIZATION;

EID: 2442526137     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.5.1657     Document Type: Article

References (36)

1. Hansen EF, Rappeport Y, Vestbo J, et al. Increase in prevalence and severity of asthma in young adults in Copenhagen. Thorax 2000; 55:835-836
2. European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996; 9:687-695
3. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998; 12:315-335
4. Manfreda J, Becklake MR, Sears MR, et al. Prevalence of asthma symptoms among adults aged 20-44 years in Canada. Can Med Assoc J 2001; 164:995-1001
5. Habbick BF, Pizzichini MMM, Taylor B, et al. Prevalence of asthma, rhinitis and eczema among children in 2 Canadian cities: the International Study of Asthma and Allergies in Childhood. Can Med Assoc J 1999; 160:1824-1828
6. Lundback B, Ronmark E, Jonsson E, et al. Incidence of physician-diagnosed asthma in adults: a real incidence or a result of increased awareness? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2001; 95:685-692
7. Toelle BG, Peat JK, Salome CM, et al. Towards a definition of asthma for epidemiology. Am Rev Respir Dis 1992; 146:633-637
8. Burney PGJ, Luczynska C, Chinn S, et al. The European Community Respiratory Health Survey. Eur Respir J 1994; 7:954-960
9. 20 with two alternative measures of response to histamine challenge in epidemiological studies. Eur Respir J 1993; 6:670-679
10. European Commission, Directorate General XII. Protocol for the European Community Respiratory Health Survey. Luxembourg: Office for Official Publications, 1993
11. American Thoracic Society. Standardization of spirometry, 1987 update. Am Rev Respir Dis 1987; 136:1285-1298
12. Enright PL, Johnson LR, Connett JE, et al. Spirometry in the lung Health Study: 1. Methods and quality control. Am Rev Respir Dis 1991; 143:1215-1223
13. Chinn S, Burney P, Jarvis D, et al, on behalf of the European Community Respiratory Health Survey (ECRHS). Variation in bronchial responsiveness in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1997; 10:2495-2501
14. Chinn S. Methodology of bronchial responsiveness. Thorax 1998; 53:984-988
15. Armitage P, Berry G, Matthews JNS. Statistical methods in medical research. 4th ed. Oxford, UK: Blackwell Science, 2002
16. Burrows B, Sears MR, Flannery EM, et al. Relations of bronchial responsiveness to allergy skin test reactivity, lung function, respiratory symptoms, and diagnoses in thirteen year old New Zealand children. J Allergy Clin Immunol 1995; 95:548-556
17. Basagana X, Sunyer J, Zock J-P, et al. Incidence of asthma and its determinants among adults in Spain. Am J Respir Crit Care Med 2001; 164:1133-1137
18. Richter K, Heinrich J, Jorres RA, et al, for the INGA Study Group. Trends in bronchial hyperresponsiveness, respiratory symptoms and lung function among adults: West and East Germany. Respir Med 2000; 94:668-677
19. Sears MR. The definition and diagnosis of asthma. Allergy 1993; 48:12-16
20. Chinn S, Jarvis D, Luczynska C, et al. Individual allergens as risk factors for bronchial responsiveness in young adults. Thorax 1998; 53:662-667
21. Chinn S, Arossa WA, Jarvis DL, et al. Variation in nebulizer aerosol output and weight output from the Mefar dosimeter: implications for multicentre studies. Eur Respir J 1997; 10:452-456
22. Leynaert B, Liard R, Bousquet J, et al. Lessons from the French part of the European Community Respiratory Health Survey (ECRHS). Allergy Clin Immunol Int 1999; 11:218-225
23. Norrman E, Plaschke P, Bjornsson E, et al. Prevalence of bronchial hyper-responsiveness in the southern, central and northern parts of Sweden. Respir Med 1998; 92:480-487
24. Leynaert B, Bousquet J, Heniy C, et al. Is bronchial hyperresponsiveness more frequent in women than in men? A population based study. Am J Respir Crit Care Med 1997; 156:1413-1420
25. 1. Am J Respir Crit Care Med 2001; 165:327-331
26. Ichinose M, Takahashi T, Sugiura H, et al. Baseline airway responsiveness and its reversible component: role of airway inflammation and airway calibre. Eur Respir J 2000; 15:248-253
27. Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax 1999; 54:1119-1138
28. Kauffmann F, Becklake MR. Maladies obstructives pulmonaires: un paradigme de la complexite des differences de sante entre hommes et femmes. In: Saurel-Cubizolles MJ, Blondell B, eds. La sante des femmes. Paris, France: Flammarion, Medecine et Sciences, 1996; 209-233
29. De Marco R, Locatelli F, Sunyer J, et al, and the European Community Respiratory Health Survey Study Group. Differences in incidence of reported asthma related to age in men and women: a retrospective analysis of the data of the European Respiratory Health Survey. Am J Respir Crit Care Med 2000; 162:68-74
30. Troisi RJ, Speizer FE, Willett WC, et al. Menopause, post-menopausal estrogen preparations, and the risk of adult-onset asthma. Am J Respir Crit Care Med 1995; 152:1183-1188
31. Mueller JE, Frye C, Brasche S, et al. Association of hormone replacement therapy with bronchial hyper-responsiveness. Respir Med 2003; 97:990-992
32. Haggerty CL, Ness RB, Kelsey S, et al. The impact of estrogen and progesterone on asthma. Ann Allergy Asthma Immunol 2003; 90:284-291
33. Janson C, Chinn S, Jarvis D, et al, on behalf of the European Community Respiratory Health Survey. Physician-diagnosed asthma and drug utilization in the European Respiratory Health Survey. Eur Respir J 1997; 10:1795-1802
34. Ulrik CS, Backer V. Longitudinal determinants of bronchial responsiveness to inhaled histamine. Chest 1998; 113:973-979
35. Siersted HC, Walker CM, O'Shaughnessy AD, et al. Comparison of two standardized methods of methacholine inhalation challenge in young adults. Eur Respir J 2000; 15:181-184
36. Cockroft DW, Killian DN, Melon JA, et al. Bronchial reactivity to inhaled histamine: a method and a clinical survey. Clin Allergy 1977; 7:235-243